Concepedia

Inge Verbrugge

IV

Statistics

Publications

19

Citations

1.4K

H-Index

17

Active since

2006

Affiliations

The Netherlands Cancer Institute(Current)

Oncode Institute

Peter MacCallum Cancer Centre

The University of Melbourne

Juntendo University

Inge Verbrugge is an author at The Netherlands Cancer Institute specializing in oncology, cancer immunotherapy, and medicine.

ORCID

Publications per year

2006–2024

19

Publications

19

Radiotherapy Increases the Permissiveness of Established Mammary Tumors to Rejection by Immunomodulatory Antibodies

Inge Verbrugge, Jim Hagekyriakou, Leslie L. Sharp et al. · Cancer Research · 2012 · 273 citations · Full text

, , +17

Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma

Marcel A. Deken, Jules Gadiot, Ekaterina S. Jordanova et al. · OncoImmunology · 2016 · 146 citations · Full text

, , +17

Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors

Michael Bots, Inge Verbrugge, Benjamin Martin et al. · Blood · 2014 · 136 citations · Full text

, , +16

The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia

Adele Baker, Gareth P. Gregory, Inge Verbrugge et al. · Cancer Research · 2015 · 119 citations

, , +17

SnapShot: Extrinsic Apoptosis Pathways

Inge Verbrugge, Ricky W. Johnstone, Mark J. Smyth · Cell · 2010 · 95 citations · Full text

, , +12

1–5 of 19